search
Back to results

Treatment Study of Soft Palatal Implants in Obstructive Sleep Apnea

Primary Purpose

Sleep Apnea, Obstructive

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
soft palate implant
Positive airway pressure (PAP)
Sponsored by
Mayo Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sleep Apnea, Obstructive

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

INCLUSION CRITERIA Age >18 yrs AHI 5-30 Tonsil size <50% of airway No anatomically fixed nasal stenosis BMI = 32 kg/m2 EXCLUSION CRITERIA 1. The presence of a concomitant untreated primary sleep disorder (restless legs syndrome, narcolepsy, idiopathic hypersomnia) 2. Severe daytime sleepiness (history of sleep-related motor vehicle or occupational accident) 3. Moderate to severe pulmonary disease (FEV1 <50% pred) 4. Neurologic impairment (h/o CVA, TIA, neuromuscular disease, diaphragmatic paralysis) 5. Significant cardiac disease (LVEF<50%, moderate to severe valvular disease) 6. Uncontrolled hypertension >180/110 7. Renal disease (Scr > 2.5) 8. Allergy to local anesthetics used for implantation procedure. 9. Pregnant or nursing women

Sites / Locations

  • Mayo Clinic

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Other

Active Comparator

Sham Comparator

Arm Label

Positive airway pressure (PAP)

outpatient surgical procedure

Sham surgery

Arm Description

which is air delivered by a mask worn over the nose during sleep

where small fabric rods are inserted into the soft palate (the fleshy portion of the roof of the mouth) to stiffen the tissues.

an outpatient surgical procedure identical to #2 except that no rods are inserted into the soft palate.

Outcomes

Primary Outcome Measures

apnea-hypopnea index

Secondary Outcome Measures

sleepiness
quality of life
ambulatory blood pressure
snoring

Full Information

First Posted
December 7, 2005
Last Updated
May 18, 2011
Sponsor
Mayo Clinic
Collaborators
Medtronic Xomed, Inc., ResMed Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00263770
Brief Title
Treatment Study of Soft Palatal Implants in Obstructive Sleep Apnea
Official Title
A Randomized, Controlled Treatment Trial of Soft Palatal Implants and Positive Airway Pressure in Mild to Moderate Obstructive Sleep Apnea and Snoring
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Completed
Study Start Date
December 2005 (undefined)
Primary Completion Date
October 2007 (Actual)
Study Completion Date
October 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Mayo Clinic
Collaborators
Medtronic Xomed, Inc., ResMed Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to compare the effectiveness of soft palatal implants with placebo and continuous positive airway pressure treatment in obstructive sleep apnea.
Detailed Description
Obstructive sleep apnea (OSA), frequently associated with disruptive snoring, is a prevalent disorder which is increasingly recognized by health care providers and lay people alike as an important factor in impaired daytime executive function as well as cardiovascular disease risk. Along with an increase in its recognition and diagnosis have come a growing pool of patients with milder disease and the associated challenge of ideal management. Positive airway pressure (PAP) is well established as the mainstay of treatment for OSA since it is effective at reversing daytime neurocognitive sequelae and may be a useful adjunct to therapy in those with cardiovascular disease coexisting with OSA. In patients with mild OSA, however, the response to PAP therapy appears muted, which is related in part to poor adherence to treatment. In response, a number of alternative treatments have evolved. The most recent innovation is soft palatal implants, which, in non-randomized, uncontrolled studies have demonstrated reasonable efficacy in the treatment of snoring and mild to moderate OSA. How the implants compare with standard therapy and their effect on cardiovascular variables are unknown. Because of the ease and rapidity with which this system is implanted, and because treatment effect is independent of patient compliance, there is high potential for widespread use in patients with milder OSA. We therefore are conducting a randomized, placebo-controlled clinical trial to compare the impact of palatal implants with PAP on sleep disordered breathing, daytime symptoms and blood pressure, as well as patient / bed partner acceptance.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea, Obstructive

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
64 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Positive airway pressure (PAP)
Arm Type
Other
Arm Description
which is air delivered by a mask worn over the nose during sleep
Arm Title
outpatient surgical procedure
Arm Type
Active Comparator
Arm Description
where small fabric rods are inserted into the soft palate (the fleshy portion of the roof of the mouth) to stiffen the tissues.
Arm Title
Sham surgery
Arm Type
Sham Comparator
Arm Description
an outpatient surgical procedure identical to #2 except that no rods are inserted into the soft palate.
Intervention Type
Device
Intervention Name(s)
soft palate implant
Intervention Type
Other
Intervention Name(s)
Positive airway pressure (PAP)
Intervention Description
which is air delivered by a mask worn over the nose during sleep
Primary Outcome Measure Information:
Title
apnea-hypopnea index
Time Frame
90 days
Secondary Outcome Measure Information:
Title
sleepiness
Time Frame
90 days
Title
quality of life
Time Frame
90 days
Title
ambulatory blood pressure
Time Frame
90 days
Title
snoring
Time Frame
90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
INCLUSION CRITERIA Age >18 yrs AHI 5-30 Tonsil size <50% of airway No anatomically fixed nasal stenosis BMI = 32 kg/m2 EXCLUSION CRITERIA 1. The presence of a concomitant untreated primary sleep disorder (restless legs syndrome, narcolepsy, idiopathic hypersomnia) 2. Severe daytime sleepiness (history of sleep-related motor vehicle or occupational accident) 3. Moderate to severe pulmonary disease (FEV1 <50% pred) 4. Neurologic impairment (h/o CVA, TIA, neuromuscular disease, diaphragmatic paralysis) 5. Significant cardiac disease (LVEF<50%, moderate to severe valvular disease) 6. Uncontrolled hypertension >180/110 7. Renal disease (Scr > 2.5) 8. Allergy to local anesthetics used for implantation procedure. 9. Pregnant or nursing women
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sean M. Caples, D.O.
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Treatment Study of Soft Palatal Implants in Obstructive Sleep Apnea

We'll reach out to this number within 24 hrs